Xydalba
- Licence status
- Active substances
- Dalbavancin hcl
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/14/986/001
- Licence holder
- AbbVie Deutschland GmbH & Co. KG
Product documents
Licence information
- ATC code
- J01XA Glycopeptide antibacterials, J01XA04 dalbavancin
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 19/02/2015